X Ventures Competitors

Summit Partners is a global alternative investment firm with capital dedicated to growth equity, fixed income, and public equity opportunities. The Summit Partners’ strategy is grounded in a foundational belief that profitable growth is the most reliable path to building a durable business and creating long-term value. For four decades, the Summit team has focused on partnering with and powering the growth of great people and great companies. Summit invests across growth sectors of the economy and has invested in more than 550 companies in technology, healthcare, and other growth industries including financial services, consumer, business services and industrial technology. These companies have completed more than 175 public equity offerings, and more than 250 have been acquired through strategic mergers and sales. Summit maintains offices in North America and Europe and invests in companies around the world.

Element Capital is an alternative investment manager utilizing a Modern Macro style of global macro investing, an evolved approach that integrates macro fundamental, systematic, and relative value analysis in the formation and implementation of directional views. Jeffrey Talpins, Founder and CIO, launched Element’s flagship hedge fund in April 2005. Since those early days, the investing landscape has changed radically as new approaches and technologies have impacted financial markets around the world. We believe that our ability to synthesize qualitative and quantitative disciplines – bringing deeply informed human judgment to bear on global macroeconomic issues – has allowed Element to endure and thrive. Element Capital’s team is unique, lean, and focused. With offices in New York and London, Element is comprised of approximately 60 driven and diverse professionals. Our team includes investment specialists, economists, technologists and business operations experts, all working together to deliver a highly efficient, best-in-class investment firm. Please reach out to careers@elementcapital.com to inquire about opportunities and visit our website to learn more about life Element.

Skyline Ventures, formed in 1997, is a nationally-known venture capital firm that specializes in investing in outstanding product-focused healthcare companies. Our areas of expertise include small molecule and protein therapeutics; medical devices; diagnostics; and technologies that facilitate drug discovery and life science research.